OUR HISTORY
A Legacy of Medical Intelligence. A Vision for Global Bioinnovation.
The EXODIAMOND story is shaped by a professional journey that began in 1993 and evolved through international medical technology, multidisciplinary expertise, strategic brand development and biotechnology. Each stage has contributed a distinct capability to the vision represented by EXODIAMOND today.
01 | 1993 — The Foundation of Medical Intelligence
Our foundations reach back to 1993, marking the beginning of a professional journey in the medical technology sector. Direct engagement with medical devices, clinical environments and the demands of healthcare markets established a practical understanding of how technology, professional expectations and commercial responsibility intersect.
Over time, that experience developed into a broader perspective: successful medical technology businesses depend on informed product selection, dependable market relationships, technical understanding and sustained execution.
02 | Multidisciplinary Expertise on a Global Stage
Experience across 18 medical specialties and international medical device markets expanded this foundation into a multidisciplinary body of knowledge. Exposure to established global medical technology brands and diverse product categories created an informed view of clinical environments, technology adoption and the standards expected of professional suppliers.
The scope of this experience extends across market assessment, international distribution, hospital and healthcare-sector engagement, product development, regulatory coordination, certification processes, commercial strategy and brand development. Together, these disciplines form a practical intelligence base for evaluating opportunities and building durable market relationships.
03 | From Sector Experience to Strategic Brand Architecture
As this professional journey progressed, its focus expanded from individual technologies and market activities to the design of integrated commercial frameworks. International market intelligence, manufacturer engagement, regulatory awareness, product positioning and long-term partner development became connected elements of a wider strategy.
This progression informed an approach to brand building grounded in defined responsibilities, coordinated expertise and the ability to translate technical potential into coherent international market propositions.
04 | London — A Platform for Global Commercialisation
IMD GLOBAL UK LIMITED provides the London-based corporate foundation for EXODIAMOND brand ownership and global commercialisation. Its role brings together international brand direction, market development, commercial coordination and the structured management of professional partnerships.
This framework is designed to support consistent brand representation across markets while respecting the distinct responsibilities of manufacturing, regulatory processes and local commercial partners.
05 | Where Medical Intelligence Meets Biotechnology Excellence
A defining development in this journey is the collaboration with EXOMEDI, the South Korean manufacturer behind the EXODIAMOND product platform. EXOMEDI contributes specialised biotechnology knowledge, manufacturing capabilities and a technology-led approach to product development.
The relationship brings complementary strengths into a common direction: IMD’s international medical technology experience and global brand-commercialisation perspective, together with EXOMEDI’s biotechnology and manufacturing expertise. This alignment provides a substantive foundation for the development and international positioning of EXODIAMOND.
The manufacturer’s technical capabilities and quality documentation are addressed within their applicable scope, with the respective corporate responsibilities of IMD and EXOMEDI clearly defined.
06 | EXODIAMOND — The Vision Takes Form
EXODIAMOND expresses the evolution of this experience into a distinct international brand identity. Its EXOTRIO platform brings together three defined plant-derived biological sources—Panax ginseng, Houttuynia cordata and Rose of Jericho—within a coordinated cosmetic product architecture.
The brand’s direction combines biological-source identity, scientific discipline, manufacturing assurance, product documentation and London-based global commercialisation. These elements are reflected in a consistent ambition: to build lasting value through clarity of purpose, precision of execution and responsible international development.
THE JOURNEY CONTINUES
From London to the World.
From the foundations of medical technology experience in 1993 to the development of EXODIAMOND and EXOTRIO, the journey reflects a continuing commitment to international expertise, purposeful collaboration and enduring brand value.
EXODIAMOND · EXOTRIO · Beyond Expectation.